Clinical Trial Update: A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase I/II open-label clinical trial evaluating the safety, tolerability, PK, and preliminary efficacy of FB849 in patients with advanced solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• FB849

Snippet

Sponsor: 1ST Biotherapeutics, Inc. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING